Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy

被引:33
|
作者
Bijman, Rik G. [1 ]
Breedveld, Sebastiaan [1 ]
Arts, Tine [1 ]
Astreinidou, Eleftheria [2 ]
de Jong, Martin A. [2 ]
Granton, Patrick V. [1 ]
Petit, Steven F. [1 ]
Hoogeman, Mischa S. [1 ]
机构
[1] Erasmus MC Canc Inst, Dept Radiat Oncol, POB 5201, NL-3008 AE Rotterdam, Netherlands
[2] LUMC, Dept Radiat Oncol, Leiden, Netherlands
关键词
COMPLICATION PROBABILITY; SETUP UNCERTAINTIES; RADIOTHERAPY; OPTIMIZATION; HEAD; ROBUSTNESS; RANGE;
D O I
10.1080/0284186X.2017.1355113
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Proton therapy is becoming increasingly available, so it is important to apply objective and individualized patient selection to identify those who are expected to benefit most from proton therapy compared to conventional intensity modulated radiation therapy (IMRT). Comparative treatment planning using normal tissue complication probability (NTCP) evaluation has recently been proposed. This work investigates the impact of NTCP model and dose uncertainties on model-based patient selection. Material and Methods: We used IMRT and intensity modulated proton therapy (IMPT) treatment plans of 78 oropharyngeal cancer patients, which were generated based on automated treatment planning and evaluated based on three published NTCP models. A reduction in NTCP of more than a certain threshold (e.g. 10% lower NTCP) leads to patient selection for IMPT, referred to as 'nominal' selection. To simulate the effect of uncertainties in NTCP-model coefficients (based on reported confidence intervals) and planned doses on the accuracy of model-based patient selection, the Monte Carlo method was used to sample NTCP-model coefficients and doses from a probability distribution centered at their nominal values. Patient selection accuracy within a certain sample was defined as the fraction of patients which had similar selection in both the 'nominal' and 'sampled' scenario. Results: For all three NTCP models, the median patient selection accuracy was found to be above 70% when only NTCP-model uncertainty was considered. Selection accuracy decreased with increasing uncertainty resulting from differences between planned and delivered dose. In case of excessive dose uncertainty, selection accuracy decreased to 60%. Conclusion: Model and dose uncertainty highly influence the accuracy of model-based patient selection for proton therapy. A reduction of NTCP-model uncertainty is necessary to reach more accurate model-based patient selection.
引用
收藏
页码:1444 / 1450
页数:7
相关论文
共 50 条
  • [21] The impact of dose algorithms on tumor control probability in intensity-modulated proton therapy for breast cancer
    Liang, Xiaoying
    Bradley, Julie A.
    Zheng, Dandan
    Rutenberg, Michael
    Vega, Raymond Mailhot
    Mendenhall, Nancy
    Li, Zuofeng
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2019, 61 : 52 - 57
  • [22] Feature Selection for Surrogate Model-Based Optimization
    Rehbach, Frederik
    Gentile, Lorenzo
    Bartz-Beielstein, Thomas
    PROCEEDINGS OF THE 2019 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE COMPANION (GECCCO'19 COMPANION), 2019, : 399 - 400
  • [23] Modeling the Potential Benefits of Proton Therapy for Patients With Oropharyngeal Head and Neck Cancer
    Lester-Coll, Nataniel H.
    Margalit, Danielle N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (03): : 563 - 566
  • [24] PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection
    Rojo-Santiago, Jesus
    Korevaar, Erik
    Perko, Zoltan
    Both, Stefan
    Habraken, Steven J. M.
    Hoogeman, Mischa S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 186
  • [25] Present developments in reaching an international consensus for a model-based approach to particle beam therapy
    Prayongrat, Anussara
    Umegaki, Kikuo
    van der Schaaf, Arjen
    Koong, Albert C.
    Lin, Steven H.
    Whitaker, Thomas
    McNutt, Todd
    Matsufuji, Naruhiro
    Graves, Edward
    Mizuta, Masahiko
    Ogawa, Kazuhiko
    Date, Hiroyuki
    Moriwaki, Kensuke
    Ito, Yoichi M.
    Kobashi, Keiji
    Dekura, Yasuhiro
    Shimizu, Shinichi
    Shirato, Hiroki
    JOURNAL OF RADIATION RESEARCH, 2018, 59 : I72 - I76
  • [26] Model-based rational strategy for chromatographic resin selection
    Nfor, Beckley K.
    Zuluaga, Diego S.
    Verheijen, Peter J. T.
    Verhaert, Peter D. E. M.
    van der Wielen, Luuk A. M.
    Ottens, Marcel
    BIOTECHNOLOGY PROGRESS, 2011, 27 (06) : 1629 - 1643
  • [27] Evaluation of an automated clinical decision system with deep learning dose prediction and NTCP model for prostate cancer proton therapy
    Chen, Mei
    Pang, Bo
    Zeng, Yiling
    Xu, Cheng
    Chen, Jiayi
    Yang, Kunyu
    Chang, Yu
    Yang, Zhiyong
    PHYSICS IN MEDICINE AND BIOLOGY, 2024, 69 (11)
  • [28] Model based patient pre-selection for intensity-modulated proton therapy (IMPT) using automated treatment planning and machine learning
    Kouwenberg, Jasper
    Penninkhof, Joan
    Habraken, Steven
    Zindler, Jaap
    Hoogeman, Mischa
    Heijmen, Ben
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : 224 - 229
  • [29] Hypofractionated proton therapy for prostate cancer: Dose delivery uncertainty due to interfractional motion
    Wang, Yi
    Efstathiou, Jason A.
    Lu, Hsiao-Ming
    Sharp, Gregory C.
    Trofimov, Alexei
    MEDICAL PHYSICS, 2013, 40 (07)
  • [30] A deep learning model for predicting the modified micro-dosimetric kinetic model-based dose and the dose-averaged linear energy transfer for prostate cancer in carbon ion therapy
    Zhang, Liwen
    Wang, Weiwei
    Li, Ping
    Zhang, Qing
    Han, Rongcheng
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2024, 32